Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin dosing in high flux hemodialysis: a limited-sampling algorithm.

Amy Barton Pai1, Manjunath P Pai

  • 1College of Pharmacy, University of New Mexico, Albuquerque 87131, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|October 7, 2004
PubMed
Summary

A revised vancomycin dosing algorithm for hemodialysis patients significantly reduced drug monitoring. This new approach achieved comparable therapeutic vancomycin levels and resulted in substantial cost savings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenging Weight-Tiered Antibiotic Prophylaxis in Obese Patients Undergoing Colorectal Surgery Using CT-Derived Body Composition.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.

Clinical pharmacology and therapeutics·2026
Same author

Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient Setting.

Open forum infectious diseases·2026
Same author

Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling.

Antimicrobial agents and chemotherapy·2026
Same author

Translating Antibiotic Concentrations From Whole Blood to Plasma in Volumetric Absorptive Microsampling Applications: Letter to the Editor.

Therapeutic drug monitoring·2026

Area of Science:

  • Nephrology
  • Pharmacology
  • Infectious Diseases

Background:

  • Vascular-access-related bacteremia is a common complication in hemodialysis patients.
  • Vancomycin is frequently used to treat these infections, requiring careful therapeutic drug monitoring.
  • Traditional vancomycin dosing algorithms in hemodialysis necessitate frequent serum concentration measurements.

Purpose of the Study:

  • To investigate the feasibility of a limited-sampling vancomycin dosing algorithm.
  • To assess its effectiveness in outpatient high-flux hemodialysis for bacteremia.
  • To evaluate potential cost savings associated with a simplified monitoring approach.

Main Methods:

  • Retrospective analysis of vancomycin concentration data from an established dosing algorithm.

Related Experiment Videos

  • Evaluation of pharmacokinetic parameters and vancomycin removal rates during hemodialysis.
  • Implementation and retrospective analysis of a revised, limited-sampling vancomycin dosing algorithm.

    • Main Results:

    • The original algorithm yielded 97% of vancomycin concentrations within the target range (5-20 microg/mL).
    • Mean vancomycin removal during hemodialysis was 39% +/- 13%.
    • The revised limited-sampling algorithm reduced vancomycin concentration determinations by 70%, with 93% of levels remaining therapeutic, and estimated annual cost savings of $7552.

    Conclusions:

    • A vancomycin dosing algorithm with limited concentration monitoring is feasible for hemodialysis patients.
    • This approach achieves comparable therapeutic vancomycin concentrations to more intensive monitoring.
    • The revised algorithm offers significant cost savings for hemodialysis units.